Involvement of nitric oxide in peripheral antinociception mediated by κ-and δ-opioid receptors

Anesthesia and Analgesia

Volumn 87, Issue 2, 1998, Pages 388-393

  Nozaki Taguchi, Natsuko ^a   Yamamoto, Tatsuo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MW 327; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TACROLIMUS; UNCLASSIFIED DRUG;

AGITATION; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; BENZOATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; FORMALDEHYDE; IMIDAZOLES; MALE; NITRIC OXIDE; NITRO COMPOUNDS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA;

EID: 0031854337     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199808000-00028     Document Type: Article

References (23)

1. Fields HL, Emson PC, Leigh BK, et al. Multiple opiate receptor sites on primary afferent fibres. Nature 1980;284:351-4.
2. Stein C, Hassan AHS, Lehrberger K, et al. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4.
3. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg 1993;76:182-91.
4. Stein C, Millan MJ, Shippenberg TS, et al. Peripheral opioid receptors mediating antinociception in inflammation: evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989;248:1269-75.
5. Levine JD, Taiwo YO. Involvement of the μ-opiate receptor in peripheral analgesia. Neuroscience 1989;32:571-5.
6. Taiwo YO, Levine JD. κ-and δ-opioids block sympathetically dependent hyperalgesia. J Neurosci 1991;11:928-32.
7. Yaksh T. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 1988;458:319-24.
8. Duarte IDG, Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-argininenitric oxide-cGMP pathway. Eur J Pharamacol 1992;221:171-4.
9. Ferreira SH, Duarte IDG, Lorenzetti BB. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991;201:121-2.
10. Hino N, Iwami M, Okamoto M, et al. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physiochemical and biological characteristics. J Antibiot (Tokyo) 1989; 42:1578-83.
11. Kita Y, Hirasawa Y, Maeda K, et al. Spontaneous nitric oxide release accounts for the potent pharmacological action of FK409. Eur J Pharmacol 1994;257:123-30.
12. Nozaki-Taguchi N, Yamamoto T. Interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation. Anesth Analg 1998;86:367-73.
13. Akaie T, Yoshida M, Miyamoto Y, et al. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry 1993;32: 827-32.
14. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992;263:136-46.
15. Rengasamy A, Pajewski TN, Johns RA. Inhalation anesthetic effects on rat cerebellar nitric oxide and cyclic guanosine monophosphate production. Anesthesiology 1997;86:689-98.
16. Haley JE, Dickenson AH, Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992;31:251-8.
17. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994;112:547-50.
18. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30:103-14.
19. Dickenson AH, Sullivan AF. Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: different responses to an intrathecal opiate administered pre or post formalin. Pain 1987;30:349-60.
20. Salvemini D, Wang ZQ, Wyatt PS, et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996;118:829-38.
21. Anggard E. Nitric oxide: mediator, murder, and medicine. Lancet 1994;343:1199-206.
22. Stein C. Peripheral analgesic actions of opioids. J Pain Symptom Manage 1991;6:119-24.
23. Minami M, Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 1995;23: 121-45.